A concise review on Development and Assessment of Ondansetron Hydrochloride-Loaded Transdermal Patches

Reference

1. Vyas S.P., Khar R.K., Controlled Drug Delivery-Concepts and Advances, 1 st Edition, Vallabh Prakashan, 2002, 411- 445
2. Jain NK (2001) Controlled and novel drug delivery. (1st Edn.) CBS Publisher and Distributors, New Delhi, India 2001: 100-129.
3. Dhiman S, Thakur G, and Rehni A: Transdermal patches: A recent approach to new drug delivery system. International Journal of Pharmacy and Pharmaceutical Sciences., 2011; 3: 26-34.
4. Morrow DIJ, McCarron PA, Woolfson AD, and Donnelly RF: Innovative strategies for enhancing topical and transdermal drug delivery. The Open Drug Delivery Journal., 2007; 1: 36-59.
5. Tortara GJ, Bryan H. Derrickson (2011) Principles of Anatomy and Physiology, (9th Edn.) 140-94.
6. David SRN, Rajabalaya R, Zhia ES. Development and in vitro evaluation of selfadhesive matrix-type transdermal delivery system of ondansetron hydrochloride. Trop J Pharm Res. 2015;14(2):211–8.
7. Bhardwaj S, Bhatia S, Singh S. Transdermal Delivery of Ondansetron Hydrochloride in the management of Hyperemesis Gravidarum. Int J Pharma Sci Res. 2020;11(8):206–14.
8. Misra, A.N. 1997. Controlled and Novel Drug Delivery. In: Jain NK, editors. Transdermal Drug Delivery. New Delhi, India: CBS Publisher and Distributor, pp. 100-101.
9. Rajabalaya, R., Chen, D.S., David, S.R.N. 2013. Development of transdermal ondansetron hydrochloride for the treatment of chemotherapy-Induced nausea and vomiting. Trop. J. Pharm. Res. 12, 279-285.
10. Mohd, F. Bontha, L.S., Bontha, V.K., Vemula S.K. 2017. Formulation and evaluation of transdermal films of ondansetron hydrochloride. MOJ Bioequiv Availab. 3, 86-92.
11. Makoto, S.; Sierra, C.; Naoko, N.; Marina, E.; Alan, Y.; Ruxandra-Ioana, A.; Evelina, P.; Paolo, C.; Ken, Y.; Jason, H.; & Kazuyoshi, A. (2025). Effect of Ondansetron and Metoclopramide on postoperative nausea and vomiting in children undergoing tonsillectomy with or without adenoidectomy: a systematic review with meta- analysis. Journal of Anaesthesia, Vol. 39, pages 345-354, print ISSN 0913-8668 (e-ISSN) is 1438-8359
12. Chilkoti, Geetanjali T; Nandanan, Janaki; Saxena, Ashok Kumar; Seth, Varun; Kaur, Navneet1; Maurya, Prakriti. Low dose ondansteron with dexamethasone for prophylaxis of postoperative nausea and vomiting following laparoscopic cholecystectomy- A randomized double-blind study. Journal of Anaesthesiology Clinical Pharmacology, Vol. 41, No.1, (Jan-Mar 2025), pp. 84-89, Print ISSN: 0970-9185 Online ISSN: 2231-2730
13. Sunita N. Vaidya, “Innovations in Topical Drug Delivery: Recent Developments in Transdermal Formulations, Gels, and Patches as Topical Medication Delivery Methods”, AJP, vol. 18, no. 04, Dec. 2024. Print ISSN: 0973-8398, Electronic ISSN: 1998-409X
14. Patel M, Patel A, Desai J, Patel S. Cutaneous Pharmacokinetics of Topically Applied Novel Dermatological Formulations. AAPS Pharm SciTech. 2024 Feb 27;25(3):46. doi: 10.1208/s12249-024-02763-4. PMID: 38413430. ISSN (Print): 1530-9932, ISSN (Online): 1530-9932
15. Suksaeree, J., Maneewattanapinyo, P., Panrat, K. et al. Solvent?Cast Polymeric Films from Pectin and Eudragit® NE 30D for Transdermal Drug Delivery Systems. J Polym Environ 29, 3174–3184 (2021). https://doi.org/10.1007/s10924-021-02108-3, ISSN (Print): 1566-2543, ISSN (Online): 1572-8919
16. Kailash Sahu, Saman Pathan, Kapil Khatri, Neeraj Upmanyu and Satish Shilpi Development, Characterization, In Vitro and Ex Vivo Evaluation of Antiemetic Transdermal Patches of Ondansetron Hydrochloride and Dexamethasone GSC Biological and Pharmaceutical Sciences, 2021, 14(03), 067-078.
17. Bharathi, D., Reddy, C. S., Babu, G., & Shirisha, Y. (2017). Formulation and Evaluation of Ondansetron HCl Transdermal Patch. World Journal of Pharmaceutical Research, 6(16), 417–426.
18. Mohd, F., Bontha, L. S., Bontha, V. K., & Vemula, S. K. (2017). Formulation and evaluation of transdermal films of ondansetron hydrochloride. MOJ Bioequivalence & Bioavailability, 3(4), 00039.
19. Teodorescu, F., Queniat, G., Foulon, C., & Szunerits, S. (2017). Transdermal skin patch based on reduced graphene oxide: A new approach for photothermal triggered permeation of ondansetron across porcine skin. Journal of Controlled Release, 245, 137–146.
20. David, S. R. N., Rajabalaya, R., & Zhia, E. S. (2015). Development and in vitro evaluation of self-adhesive matrix-type transdermal delivery system of ondansetron hydrochloride. Tropical Journal of Pharmaceutical Research, 14(2), 211–218
21. Swain, K., Pattnaik, S., Sahu, S. C., & Mallick, S. (2009). Feasibility assessment of ondansetron hydrochloride transdermal systems: Physicochemical characterization and in vitro permeation studies. Latin American Journal of Pharmacy, 28(5), 706–714.
22. Formulation and Evaluation of Transdermal Ondansetron Hydrochloride Matrix Patch: In Vitro Skin Permeation and Irritation Study." International Journal of Pharmaceutical Research and Allied Sciences, vol. 13, no. 4, 2024
23. Pattnaik, S., Swain, K., Mallick, S., & Lin, Z. (2011). Effect of casting solvent on crystallinity of ondansetron in transdermal films. International Journal of Pharmaceutics, 406(1–2), 106–110.
24. Fathima, F., Kumar, V. B., Rudrangi, S. R. S., Vemula, S. K., Garrepally, P., & Chilukula, S. (2011). Formulation and evaluation of matrix-type transdermal delivery system of ondansetron hydrochloride using solvent casting technique. Research Journal of Pharmacy and Technology, 4(5), 806–814
25. Alok Ranjan, Aishwarya Sahu, Akansha Yadav, Alka Payasi, Akash Jaiswal, Akshay Kumar, Akash Sahu, Ashwani Jangde, Chandrashekhar Nayak, Dev Kumar, Harshita Yarda, Mitali Sahu, Nokesh Sahu, Rajesh Patel, Nisha Nair, Mukta Agrawal, Ajazuddin, D. K. Tripathi, Amit Alexander. A Short Review on the Formulation of Transdermal Dermal Drug Delivery System (TDDS). Res. J. Pharma. Dosage Forms and Tech. 2018; 10(2): 90-94.